Nov 18, 2011
Sandoz Reaches $150 Million Settlement in Drug Pricing Cases Brought by Serial Whistleblower Ven-A-Care
After 16 years and more than $2.5 billion in recoveries, Ven-A-Care’s qui tam assault on the pharmaceuticals industry is still going strong. Novartis generics unit Sandoz has agreed to pay $150 million to settle suits brought on behalf of the federal government and the states of Florida and California.